This content has been independently produced by ADG, made possible through sponsorship from Sanofi.

ATAGI has released clinical guidance on Japanese encephalitis virus vaccines following more confirmed cases in the southern states of Australia.

These recommendations follow on from earlier advice from Communicable Diseases Network Australia identifying the groups at highest risk of disease and who should be prioritised for vaccination.

Professor Allen Cheng, infectious disease physician and director, Infection Prevention Healthcare Epidemiology Unit, Alfred Health, answers eight frequently asked clinical questions about JEV vaccination.